ResMed
308 hedge funds and large institutions have $4.19B invested in ResMed in 2014 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 84 increasing their positions, 111 reducing their positions, and 39 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
77% more call options, than puts
Call options by funds: $18.1M | Put options by funds: $10.2M
23% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 39
17% more capital invested
Capital invested by funds: $3.58B → $4.19B (+$603M)
3% more funds holding
Funds holding: 300 → 308 (+8)
1.63% more ownership
Funds ownership: 52.02% → 53.65% (+1.6%)
24% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 111
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$151M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$31.6M |
| 3 |
Renaissance Technologies
New York
|
+$23.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$21.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tiger Global Management
New York
|
-$49.3M |
| 2 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$41.9M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$33.4M |
| 4 |
NC
Nicholas Company
Milwaukee,
Wisconsin
|
-$16.8M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$16.3M |
RMD Hedge Fund Activity: Q4 2014 in Review
308 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q4 2014, worth a combined $4.19B — up 17% from $3.58B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new RMD positions and 39 closed out — a net gain of 9 holders — while 84 added to existing stakes and 111 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $151M. The largest seller was Tiger Global Management, exiting entirely with an estimated $49.3M sold.
- 308 institutional investors held ResMed (RMD) as of Q4 2014, up from 300 in Q3 2014.
- Funds reported $4.19B of ResMed stock for Q4 2014, up 17% quarter-over-quarter.
- 48 funds opened new ResMed positions in Q4 2014 and 39 closed out, a net change of +9 holders.
- The largest ResMed buyer in Q4 2014 was Capital Research Global Investors, an estimated $151M added.
- The largest ResMed seller in Q4 2014 was Tiger Global Management, an estimated $49.3M sold.
Based on aggregated 13F filings for Q4 2014.